Mode
Text Size
Log in / Sign up
N/A N=803 Randomized Treatment

Promoting Successful Weight Loss in Primary Care in Louisiana

Obesity

Enrolled (actual)
803
Serious AEs
10.3%
Results posted
Dec 2020
Primary outcome: Primary: Body Weight (Percent Change) — -4.99; -0.48 percent change

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Lifestyle Counseling (Behavioral)
Age
Adult, Older Adult · 20+ yrs
Sex
All
Sponsor
Pennington Biomedical Research Center
Primary completion
Sep 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Body Weight (Percent Change)
-4.99; -0.48
SECONDARY
Waist Circumference
-4.42; 0.71
SECONDARY
Systolic Blood Pressure
1.94; 0.41
SECONDARY
Fasting Plasma Glucose
-1.25; -0.33
SECONDARY
Total Cholesterol
4.64; -1.26
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS-29) Physical Function
0.82; -0.39
SECONDARY
PROMIS-29 Anxiety
-0.92; -0.53
SECONDARY
PROMIS-29 Depression
-0.18; 0.64
SECONDARY
PROMIS-29 Fatigue
-2.82; -1.03
SECONDARY
PROMIS-29 Sleep Disturbance
-1.25; -0.35
SECONDARY
PROMIS-29 Social Functioning
1.57; 0.15
SECONDARY
PROMIS-29 Pain Interference
-1.06; 0.21
SECONDARY
PROMIS-29 Pain Intensity
-0.02; 0.21
SECONDARY
Impact of Weight on Quality of Life-Lite (IWQOL-L) Total Score
11.02; 4.36
SECONDARY
IWQOL-L Physical Function
12.31; 4.11
SECONDARY
IWQOL-L Self Esteem
14.39; 7.62
SECONDARY
IWQOL-L Sexual Life
14.32; 4.49
SECONDARY
IWQOL-L Public Distress
5.38; 2.41
SECONDARY
IWQOL-L Work/Daily Activity
5.48; 1.47
SECONDARY
Body Weight (Absolute Change)
-5.43; -0.91
SECONDARY
Diastolic Blood Pressure
-0.61; -0.64
SECONDARY
High-density Lipoprotein Cholesterol
4.16; -0.44
SECONDARY
Low-density Lipoprotein Cholesterol
3.22; -0.17
SECONDARY
Triglycerides
-11.23; -5.58

Summary

The primary aim of this trial is to develop and test the effectiveness of a 24 month, patient-centered, pragmatic and scalable obesity treatment program delivered within primary care, inclusive of an underserved population. Half of the clinics received a behavioral intervention delivered in a primary care setting and half of the clinics received usual care.

Eligibility Criteria

Inclusion Criteria

  • Age 20.0 - 75.0 years
  • BMI 30.0 - 50.0 kg/m2
  • Able to provide written informed consent
  • Willing to change diet, physical activity and weight
  • Patient of a participating clinic
  • Able to participate in scheduled sessions

Exclusion Criteria

  • Currently participating in a weight loss program
  • Current use of weight loss medication or recent weight loss (>10 lbs in last 6 months)
  • Plans to move from the area within 2 years
  • Given birth within the past year, is currently pregnant or plans to become pregnant within 2 years
  • Past bariatric surgery or plans for bariatric surgery within 2 years
  • Current major depression
  • History of suicidal behavior or diagnosed eating disorder (bulimia, anorexia)
  • Hospitalization for mental disorder or substance abuse in the previous year
  • Active cancer (except prostate, skin and thyroid if approved by physician)
  • Serious arrhythmias or cardiomyopathy
  • Severe congestive heart failure
  • Stroke or heart attack in previous six months
  • Chronic Inflammatory conditions, including but not limited to severe arthritis, lupus, or inflammatory bowel disease(i.e. Crohn's disease or ulcerative colitis)
  • Disease that is life threatening or that can interfere with or be aggravated by exercise or weight loss
  • Discretion of primary care physician or principal investigator
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02561221). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search